published Date FEB 2016

Optogenetics as a diagnostic tool in Neuroscience: Coherent, Thorlabs and Scientifica planning for expansion into untapped markets

Mordor Intelligence announces the release of their report on optogenetics market titled “Global Optogenetics Market- Growth, Trends & Forecast (2015-2020).” The report discusses optogenetics market along with an in-depth analysis of North American, European, Asian and other regional markets.

The global optogenetics market, estimated at USD 15.65 million in 2015, is projected to reach a value of USD 33.83 million in 2020. The market is anticipated to grow at a Compounded Annual Growth Rate (CAGR) of 16.66% during the forecast period 2015 to 2020.

Get the full report here:

Optogenetics is a new biological technique which allows genetically defined populations of neurons to be controlled with light, offering the ability to study the characteristics of normal/abnormal brain function. The market growth for this approach is gaining momentum as it can be utilized to develop new approaches to treat various neurological disorders, hearing impairment, retinal diseases etc.

Market segmentation is based on:

  • Light Equipment
  • Optogenetics Actuators
  • Optogenetics Sensors
  • Application

Optogenetics has a very stable, mature market due to its high demand as a diagnostic tool in the field of neuroscience; according to a study conducted by the WHO, eight out of ten disorders in the three highest disability classes are neurological disorders.

Some of the leading companies in the optogenetics market are Coherent, Inc, Thorlabs, Inc., Neuralynx, Inc, RetroSense Therapeutics, Scientifica, Kendall Research Systems, Laserglow Technologies and Shanghai Laser & Optics Century Co., Ltd., among others.

Browse related reports here:

For information regarding permissions and sales, please contact:

Download a Sample Report

Our Clients Include View All

Looking to Customize Report?